Clinical Trial: Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant Period

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647978) titled 'Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant Period' on June 10.

Brief Summary: Liver transplantation (LT) is the only curative treatment option for patients with severe liver disease. Since 2007, the implementation of the MELD score in liver transplant allocation guidelines has led to a change in the profile of transplant recipients, notably with an increase in the proportion of patients receiving transplants for severe liver failure. Thus, in 2023, nearly 40% of liver transplant recipients whose primary indication for LT was cirrhosis had a MELD score greater than 35 (ABM Scien...